These continuing medical education activities are sponsored by
These activities are supported by an educational grant from:
At the conclusion of this series participants should be able to:
Lawrence Blonde, MD, FACP, FACE Director, Ochsner Diabetes Clinical Research Unit Department of Endocrinology Ochsner Medical Center New Orleans, LA
Michael H. Davidson, MD, FACC, FACP, FNLA Professor, Director of the Lipid Clinic The University of Chicago, Pritzker School of Medicine Chicago, IL
Ralph A. DeFronzo, MD Professor of Medicine Chief, Diabetes Division University of Texas Health Science Center of San Antonio Deputy Director Texas Diabetes Institute San Antonio, TX
Vivian A. Fonseca, MD, FRCP Professor of Medicine and Pharmacology Tullis–Tulane Alumni Chair in Diabetes Chief, Section of Endocrinology Tulane University Health Sciences Center New Orleans, LA
Ronald A. Codario, MD, FACP, CCMEP
Carol H. Wysham, MD
Lawrence Blonde, MD, FACP, FACE Research Grant Support: To Ochsner for his role as investigator from Eli Lilly and Company, Novo Nordisk, and Sanofi-Aventis Speaker’s Bureau: Amylin Pharmaceuticals, Inc., Bristol-Myers Squibb/AstraZeneca, Janssen Pharmaceuticals, Inc., Johnson & Johnson Diabetes Institute, L.L.C., Merck & Co. Inc., Novo Nordisk, Sanofi-Aventis, Santarus, Vivus, Inc. Consultant: Amylin Pharmaceuticals, Inc., Eisai Inc, GlaxoSmithKline, Janssen Pharmaceuticals, Inc., Merck & Co., Inc., Novo Nordisk, Pfizer, Sanofi-Aventis, Santarus
Michael H. Davidson, MD, FACC, FACP, FNLA Consulting Fees: AbbVie, Amgen, AstraZeneca, Daiichi-Sankyo, Esperion, Lipidemx, Merck & Co., Inc. Speakers Bureau: Merck & Co., Inc. Ownership Interest: Prior to July 2013, ownership interest in Omthera Pharmaceuticals, Inc.
Ralph A. DeFronzo, MD Consulting Fees: Amylin, Bristol-Myers Squibb, Janssen, Lexicon, Novo Nordisk, Takeda Contracted Research: Amylin, Bristol-Myers Squibb, Lexicon, Takeda Speakers Bureau: Amylin, AstraZeneca, Bristol Myers Squibb, Janssen, Novo Nordisk
Vivian A. Fonseca, MD, FRCP Honoraria for Consulting Fees and Lectures: Abbott, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, Eli Lilly, GlaxoSmithKline, Novo Nordisk, PamLabs, Sanofi-Aventis, Takeda Research Support (to Tulane): Abbott, Eli Lilly, Endo Barrier, Novo Nordisk, Pan American Laboratories, Rcata, Sanofi-Aventis
Robert R. Henry, MD(Planning Committee only) Grant/Research Support: AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Sanofi-Aventis Consultant: Boehringer Ingelheim, Intarcia, Isis, Eli Lilly, Novo Nordisk, Roche/Genentech, Sanofi-Aventis Advisory Board: Amgen, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, Elcelyx, Eli Lilly, Intarcia, Johnson & Johnson/Janssen, Merck & Co., Inc., Novo Nordisk, Roche/Genentech, Sanofi-AventisReviewers report the following relationship(s):
Ronald A. Codario, MD, FACP, CCMEP No relevant financial relationships to disclose.
Carol H. Wysham, MD Consulting Fees: Boehringer Ingelheim, Eli Lilly, Janssen, Sanofi-Aventis Speaker’s Bureau: AstraZeneca, Bristol-Myers Squibb, Boehringer Ingelheim, Eli Lilly, Janssen, Medtronic, Novo Nordisk, Sanofi-Aventis Contract Research: Abbott, Bristol-Myers Squibb, Boehringer Ingelheim, Eli Lilly, Intarcia, Janssen, Merck & Co., Inc., Novo Nordisk, Sanofi-AventisVindico Medical Education staff report the following relationship(s):
No relevant financial relationships to disclose.BetterCME staff report the following relationship(s):
No relevant financial relationships to disclose.Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance. Unlabeled and Investigational Usage: The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices. Copyright Statement: Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2013. Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.